Longview Home Page Marshal Home Page Linden Home Page
Health News Health Library Health Topics Healthy Living
Today's Headlines    Health Alerts    Health News Feature   
Future of Medicine    Health Observances    Product Recalls
Illnesses & Conditions    Drug Guide    FDA Drug Approvals    Medical Tests   
Self-Help Resources    Complementary Medicine    Medline Search
Allergies    Asthma    Back Pain    Cancer    Caregiver    Depression    Diabetes    Digestive Disorders
Heart Disease    Kidney Disease    Men's Health    Parenting    Pregnancy    Senior's Health
Stress    Stroke    Women's Health
Fitness    Nutrition    Mind & Body    Family & Home
 






SEARCH



Today's Headlines

Health News
Daily articles from HealthDay News: breaking news on health issues, drug approvals and recent discoveries.

Surgery Unneeded in Most Asymptomatic Carotid Stenosis Cases


Study says drug therapy better option for 95% of patients, since stroke risk is low

THURSDAY, Sept. 25 (HealthDay News) -- The risk of stroke has become so low for patients with asymptomatic carotid stenosis (ACS), 95 percent of them would be better off receiving medical therapy rather than surgery or stenting, according to a Canadian-led study.

ACS is narrowing of the carotid (neck) artery that has not yet caused a stroke or transient ischemic attack (TIA). In the United States, one-half to two-thirds of patients who undergo revascularization surgery have no symptoms, according to background information in a University of Western Ontario new release about the study.

The less than 5 percent of ACS patients who might benefit from revascularization can be identified using a procedure called Transcranial Doppler Embolus Detection, which uses ultrasound to detect microemboli in arteries in the side of the head, said study leader Dr. David Spence, director of the Stroke Prevention and Atherosclerosis Research Centre at the university.

Microemboli are small blood clots or chunks of plaque that break off from the narrowing in the carotid artery and go into the brain arteries.

The study included 471 ACS patients -- 199 seen before 2003 and 272 seen after Jan. 1, 2003. Brain scans showed that microemboli were present in 12.6 percent of patients seen before 2003 and in 3.7 percent of patients seen after that. The decline in microemboli was associated with better control of plasma lipids and slower progression of carotid plaque, the study authors said.

"The 96 percent of patients without microemboli have only a 1 percent risk of stroke in the next year, whereas the ones with microemboli have a 14 percent risk of stroke," said Spence, a professor of neurology and clinical pharmacology. "Since the risk of surgery is 4 to 5 percent, patients without microemboli are better off with medical therapy including medications and lifestyle modifications. Only the ones with microemboli would benefit from carotid endarterectomy or stenting."

The study findings are to be presented Sept. 25 at the World Stroke Congress in Vienna, Austria.

More information

The American Heart Association has more about carotid artery disease.

SOURCE: University of Western Ontario, news release, Sept. 25, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Health News Provided By:
HealthDay


 

 
Good Shepherd Health

Data and information on this site
has been compiled for public use.
GSMC will not be held liable for
errors or inaccuracies.
Privacy & Conditions of Use Policy.
Questions/Comments? Contact
webmaster.
© 1999-2002 Good Shepherd Health System
Recommended Browsers:
Microsoft Internet Explorer
Version 4.0 or above,
Netscape Navigator 4.0 or above,
Or Any HTML 4.0 browser.

.